Live from bloombergs european headquarters. I am Francine Lacqua good we have a great lacqua. We have a great show lined up for you. The west leader economist joins us on set. That is to name a few of the guests. First of all, lets check your markets, because there is plenty going on good risk aversion swing the markets. Signs that the u. K. Markets are taking a turn. Your stoxx 600 down. The pound dropping. 20en demand we saw that year japanese government bonds, you can see it there on the screen. 0 for theng below first time ever. We also saw 10 year government yields on guilds the first time at a record low. Lets get to bloomberg first word news with their change. Nejra three of the uks largest real estate funds have frozen 9. 1 billion pounds of assets. Investments in Standard Life desha Standard Life investments have halted withdrawals because it did not they do not have enough cash to pay investors. Theresa may has taken a clearly in the race to succeed david cameron. She won the
Achilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell TherapyProfessor Swanton joins Achilles SAB member Dr. Christopher Klebanoff and Dr. John Haanen on the key opinion leader panel to discuss neoantigens a.
Professor Swanton joins Achilles SAB member Dr. Christopher Klebanoff and Dr. John Haanen on the key opinion leader panel to discuss neoantigens as valuable immunotherapy targets Virtual Roundtable
Investegate announcements from Achilles Therapeutics PLC, Achilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell Therapy